Thompson, J. E., Galton, B. C., Taylor, C., Boone, A., Heikkila, E., Cliche, D., Culp-stewart, S.,
Flanagan, J. G., Senchyna, M. 2011. US Patent Application 20110098460
The present invention relates to apoptosis specific eucaryotic initiation factor 5A (eIF-5A), referred to as apoptosis factor 5A1 or simply factor 5A1, apoptosis factor 5A1 nucleic acids and polypeptides and methods for inhibiting or suppressing apoptosis in cells using antisense nucleotides or siRNAs to inhibit expression of factor 5A1. The invention also relates to suppressing or inhibiting expression of pro-inflammatory cytokines by inhibiting expression of apoptosis factor 5A.